| Clinical data | |
|---|---|
| Other names | 4-Isobutoxy-3,5-dimethoxyphenethylamine; 3,5-Dimethoxy-4-isobutoxyphenethylamine |
| Routes of administration | Oral[1] |
| Drug class | Serotonergic psychedelic;Hallucinogen |
| ATC code |
|
| Pharmacokinetic data | |
| Duration of action | 8–14 hours[1] |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| Chemical and physical data | |
| Formula | C14H23NO3 |
| Molar mass | 253.342 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Isobuscaline (IB), also known as4-isobutoxy-3,5-dimethoxyphenethylamine, is apsychedelic drug of thephenethylamine andscaline families related tomescaline.[1][2] It is theanalogue andskeletal isomer ofbuscaline in which there is anisobutoxy group instead of abutoxy group at the 4 position.[1][2] The drug's dose range is 60 to 100 mgorally and itsduration is 8 to 14 hours.[1] Its effects included little in the way ofpsychedelic visuals, no enhancedfantasy, andbody load.[1] Thechemical synthesis of isobuscaline has been described.[2] The drug was described in thescientific literature byDaniel Trachsel in 2002.[2]
Thishallucinogen-related article is astub. You can help Wikipedia byexpanding it. |